文献速递类风湿关节炎

荷兰大型人群队列中抗瓜氨酸化蛋白抗体的阳性率与相关因素

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.
PubMed 文献 · Ann Rheum Dis · 2017-01-02

结果显示总人群 ACPA 阳性率为 1.0%,排除 RA 患者后为 0.8%;ACPA 阳性与年龄较大、女性、吸烟、关节症状、RA 及一级亲属风湿病史显著相关。

要点

  • 总人群 ACPA 阳性率 1.0%,非 RA 人群为 0.8%。
  • ACPA 阳性与年龄较大、女性、吸烟、关节症状、RA 及一级亲属风湿病史相关。
  • ACPA 阳性者中 22.4% 患有 RA。

核心结论

  • 在该大型人群为基础的研究中,ACPA 水平 ≥6.2 U/mL 的阳性率在总人群为 1.0%,排除 RA 患者后为 0.8%。
  • 年龄较大、吸烟和关节症状在 ACPA 阳性的 Lifelines 参与者中更常见。

研究设计与样本

  • ACPA 检测采用 Phadia-250 分析仪测定 anti-CCP2,水平 ≥6.2 U/mL 视为阳性。
  • RA 定义结合自我报告的 RA、因风湿适应症用药以及过去一年内就诊专科医生。

主要发现

  • ACPA 阳性与年龄较大、女性、吸烟、关节症状、RA 及一级亲属风湿病史显著相关。
  • ACPA 阳性参与者中 22.4% 患有 RA,其中 15.2% 符合本研究 RA 定义,7.2% 仅自我报告 RA。
  • 在无 RA 的参与者中,311 名(0.8%)为 ACPA 阳性。
  • 在非 RA 组中,ACPA 阳性者相比阴性者,年龄较大、吸烟和关节症状仍显著更常见。

关键数值与推荐

  • ACPA 阳性定义为 anti-CCP2 ≥6.2 U/mL。
  • 非 RA 人群 ACPA 阳性率为 0.8%(311 名)。
  • ACPA 阳性者中 RA 比例为 22.4%(15.2% 符合定义 RA,7.2% 仅自我报告 RA)。

临床怎么用

  • 在一般人群中解读 ACPA 阳性时需结合年龄、性别、吸烟史、关节症状及 RA 家族史。
  • ACPA 阳性者中多数并无 RA,非 RA 人群中 ACPA 阳性率仅 0.8%,应避免孤立解读阳性结果。

局限性

  • 本研究为横断面设计,无法推断因果关系。
  • RA 定义基于自我报告、用药和就诊信息,而非全部经临床确诊。
  • 研究人群主要为白种人,外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the prevalence of anticitrullinated protein antibodies (ACPAs) and their association with known rheumatoid arthritis (RA) risk factors in the general population. METHODS: Lifelines is a multidisciplinary prospective population-based cohort study in the Netherlands. Cross-sectional data from 40 136 participants were used. The detection of ACPA was performed by measuring anti-CCP2 on the Phadia-250 analyser with levels ≥6.2 U/mL considered positive. An extensive questionnaire was taken on demographic and clinical information, including smoking, periodontal health and early symptoms of musculoskeletal disorders. RA was defined by a combination of self-reported RA, medication use for the indication of rheumatism and visiting a medical specialist within the last year. RESULTS: Of the total 40 136 unselected individuals, 401 (1.0%) had ACPA level ≥6.2 U/mL. ACPA positivity was significantly associated with older age, female gender, smoking, joint complaints, RA and first degree relatives with rheumatism. Of the ACPA-positive participants, 22.4% had RA (15.2% had defined RA according to our criteria and 7.2% self-reported RA only). In participants without RA, 311 (0.8%) were ACPA-positive. In the non-RA group, older age, smoking and joint complaints remained significantly more frequently present in ACPA-positive compared with ACPA-negative participants. CONCLUSIONS: In this large population-based study, the prevalence of ACPA levels ≥6.2 U/mL was 1.0% for the total group and 0.8% when excluding patients with RA. Older age, smoking and joint complaints were more frequently present in ACPA-positive Lifelines participants. To our knowledge, this study is the largest study to date on ACPA positivity in the general, mostly Caucasian population.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. van Zanten A, Arends S, Roozendaal C, et al. Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands. Ann Rheum Dis. 2017. PMID: 28043998. doi:10.1136/annrheumdis-2016-209991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。